Abstract:The tumor-specific targeting of cancerostatics using polymer drug carriers represents a potential strategy to achieve an effective treatment with reduced side toxicity. Synthetic water-soluble copolymers based on N-(2-hydroxypropyl)methacrylamide (HPMA) are carriers with tunable architecture and drug loading, tumor-specific accumulation of the drug, and its controlled release. We describe a combination treatment of murine EL4 T cell lymphoma with HPMA-based star conjugates (Mw 250,000 g mol− 1) of doxorubicin (Dox) or docetaxel (Dtx) designed for enhanced tumor accumulation and combination therapy. Although the combination of linear conjugates (Mw = 28,000 g mol− 1) containing Dox or Dtx resulted in an additive effect in the treatment of the lymphoma, the opposite was observed in the combination of two star conjugates with Dox or Dtx, as the star Dtx conjugate decreased the treatment efficacy of the star Dox conjugate. The Dtx conjugate alone was virtually ineffective in the reduction of tumor growth or survival time extension; thus, a curative effect could be solely attributed to the Dox-containing conjugate. When Dtx was delivered to the tumor on the same polymer carrier as Dox, the efficacy of the Dox-induced treatment was reduced to a lesser extent. No reduction was found when Dtx was delivered by a linear polymer or applied as a free drug. The phenomenon was strictly related to the enhanced permeability and retention (EPR) effect, as it was not observed in BCL1 leukemia, a model without EPR. The diminished treatment outcome in the combination therapy with the two star conjugates was underlined by the significantly decreased accumulation of Dox in the tumor. The use of the drug-free polymer carrier instead of the Dtx-containing star conjugate did not reduce the treatment efficacy of the Dox conjugate. Thus, the physicochemical characteristics of the polymer carrier designed for tumor-specific drug delivery systems control the activity of the respective drug, leading to changes within the tumor microenvironment that can determine ultimate efficacy of the combination therapy.

Pharmaceutical composition as well as preparation method and use thereof

Bio-responsive Bletilla Striata Polysaccharide-Based Micelles for Enhancing Intracellular Docetaxel Delivery

Synthesis of Folate-conjugated Stearic Acid Grafted Bletilla Striata Polysaccharides Copolymers and Application for Delivering Antitumor Drugs As a Drug Delivery Carrier

Application of composition in preparing drugs for treating tumors and using method of composition

Drug-loaded nano-composite, preparation method thereof and application of nano-composite

Reduction sensitive type polyethylene glycol-medicament conjugate and preparation method thereof

Supramolecular polymeric prodrug micelles for efficient anticancer drug delivery

Multimedicine-resistance medicine-resistance taxane derivatives and preparation method and use thereof

Preparing Polymeric Microspheres with A Simplified Quality-By-Design Formulation Process for Sustained-Release Delivery of Native Protein Drugs

Synergic pharmaceutical composition treating tumors

Synthesis, self-assembly and drug release behaviors of a bottlebrush polymer-HCPT prodrug for tumor chemotherapy.

Bridged bis(beta-cyclodextrin)s-based polysaccharide nanoparticles for controlled paclitaxel delivery

pH-sensitive pullulan ramification nano-drug carrier, drug-carrying particle and preparation of pH-sensitive pullulan ramification nano-drug carrier and drug-carrying particle

Tumor-targeted sound and light power medicine-carrying nanometer nano-micelle, and preparation method and purpose thereof

Drug -driven self-assembly of pH-sensitive nano-vesicles with high loading capacity and anti-tumor efficacy?

Novel Biodegradable Polylactide/poly(ethylene glycol) Micelles Prepared by Direct Dissolution Method for Controlled Delivery of Anticancer Drugs

Fluorinated Polymeric Surfactant with a Pluronic-like Structure and Its Application as a Drug Carrier

Formulation, Pharmacokinetic Evaluation and Cytotoxicity of an Enhanced- penetration Paclitaxel Nanosuspension.

High drug loading and pH-responsive nanomedicines driven by dynamic boronate covalent chemistry for potent cancer immunotherapy

Synergistic Therapy of a Naturally Inspired Glycopolymer‐Based Biomimetic Nanomedicine Harnessing Tumor Genomic Instability

Nanometer particle loaded with doxorubicin hydrochloride as well as preparation method and purpose thereof